These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26318424)

  • 21. [Study on RNA interference silencing hMSH2 induces the reversal chemo-resistance of ovarian carcinoma cell line OC3/TAX300].
    Wang A; Li J; Li H
    Zhonghua Fu Chan Ke Za Zhi; 2014 Mar; 49(3):213-7. PubMed ID: 24820308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells.
    Takayama K; Tsutsumi S; Katayama S; Okayama T; Horie-Inoue K; Ikeda K; Urano T; Kawazu C; Hasegawa A; Ikeo K; Gojyobori T; Ouchi Y; Hayashizaki Y; Aburatani H; Inoue S
    Oncogene; 2011 Feb; 30(5):619-30. PubMed ID: 20890304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paclitaxel (Taxol) upregulates expression of functional interleukin-6 in human ovarian cancer cells through multiple signaling pathways.
    Wang TH; Chan YH; Chen CW; Kung WH; Lee YS; Wang ST; Chang TC; Wang HS
    Oncogene; 2006 Aug; 25(35):4857-66. PubMed ID: 16547493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular description of evolving paclitaxel resistance in the SKOV-3 human ovarian carcinoma cell line.
    Lamendola DE; Duan Z; Yusuf RZ; Seiden MV
    Cancer Res; 2003 May; 63(9):2200-5. PubMed ID: 12727840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Androgen-regulated genes differentially modulated by the androgen receptor coactivator L-dopa decarboxylase in human prostate cancer cells.
    Margiotti K; Wafa LA; Cheng H; Novelli G; Nelson CC; Rennie PS
    Mol Cancer; 2007 Jun; 6():38. PubMed ID: 17553164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Androgen receptor level controlled by a suppressor complex lost in an androgen-independent prostate cancer cell line.
    Wang LG; Ossowski L; Ferrari AC
    Oncogene; 2004 Jul; 23(30):5175-84. PubMed ID: 15156193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of Tyro3 receptor tyrosine kinase leads to the acquisition of taxol resistance in ovarian cancer cells.
    Lee C
    Mol Med Rep; 2015 Jul; 12(1):1485-92. PubMed ID: 25815442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation.
    Chen SY; Cai C; Fisher CJ; Zheng Z; Omwancha J; Hsieh CL; Shemshedini L
    Oncogene; 2006 Nov; 25(54):7212-23. PubMed ID: 16732317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ErbB3-binding protein Ebp1 suppresses androgen receptor-mediated gene transcription and tumorigenesis of prostate cancer cells.
    Zhang Y; Wang XW; Jelovac D; Nakanishi T; Yu MH; Akinmade D; Goloubeva O; Ross DD; Brodie A; Hamburger AW
    Proc Natl Acad Sci U S A; 2005 Jul; 102(28):9890-5. PubMed ID: 15994225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The selection of taxol resistance associated genes in ovarian cancer cell line by mRNA DD].
    Cheng G; Tian F; Li Y
    Zhonghua Yi Xue Za Zhi; 2000 Jul; 80(7):541-3. PubMed ID: 11798816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
    Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
    Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A BTB/POZ gene, NAC-1, a tumor recurrence-associated gene, as a potential target for Taxol resistance in ovarian cancer.
    Ishibashi M; Nakayama K; Yeasmin S; Katagiri A; Iida K; Nakayama N; Fukumoto M; Miyazaki K
    Clin Cancer Res; 2008 May; 14(10):3149-55. PubMed ID: 18483383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression of COP9, JAK2, HSP and NADH in ovarian carcinoma tissues after taxol-chemotherapy and their significance].
    Li HX
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jul; 43(7):528-32. PubMed ID: 19080518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpressed androgen receptor linked to p21WAF1 silencing may be responsible for androgen independence and resistance to apoptosis of a prostate cancer cell line.
    Wang LG; Ossowski L; Ferrari AC
    Cancer Res; 2001 Oct; 61(20):7544-51. PubMed ID: 11606392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
    Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
    Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modification of androgen receptor function by IGF-1 signaling implications in the mechanism of refractory prostate carcinoma.
    Yanase T; Fan W
    Vitam Horm; 2009; 80():649-66. PubMed ID: 19251054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Castration resistance of prostate cancer cells caused by castration-induced oxidative stress through Twist1 and androgen receptor overexpression.
    Shiota M; Yokomizo A; Tada Y; Inokuchi J; Kashiwagi E; Masubuchi D; Eto M; Uchiumi T; Naito S
    Oncogene; 2010 Jan; 29(2):237-50. PubMed ID: 19802001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of the structural region of taxol that may be responsible for cytokine gene induction and cytotoxicity in human ovarian cancer cells.
    Watson JM; Kingston DG; Chordia MD; Chaudhary AG; Rinehart CA; Haskill JS
    Cancer Chemother Pharmacol; 1998; 41(5):391-7. PubMed ID: 9523735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Androgen receptor-mediated repression of novel target genes.
    Prescott J; Jariwala U; Jia L; Cogan JP; Barski A; Pregizer S; Shen HC; Arasheben A; Neilson JJ; Frenkel B; Coetzee GA
    Prostate; 2007 Sep; 67(13):1371-83. PubMed ID: 17624924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and characterization of five cell models for chemoresistance studies of human ovarian carcinoma.
    Li L; Luan Y; Wang G; Tang B; Li D; Zhang W; Li X; Zhao J; Ding H; Reed E; Li QQ
    Int J Mol Med; 2004 Aug; 14(2):257-64. PubMed ID: 15254775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.